{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:19:03Z","timestamp":1789654743694,"version":"4.0.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.pop.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T08:41:13Z","timestamp":1554108073000},"page":"265-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hematuria"],"prefix":"10.1016","volume":"46","author":[{"given":"Leah M.","family":"Peterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry S.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2019.02.008_bib1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamainternmed.2017.0739","article-title":"Cost-effectiveness of common diagnostic approaches for evaluation of asymptomatic microscopic hematuria","volume":"6","author":"Halpern","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.pop.2019.02.008_bib2","first-page":"524","article-title":"A\u00a0prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice","volume":"163","author":"Khadra","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2019.02.008_bib3","first-page":"2473","article-title":"Diagnosis, evaluation and follow-up of asymptomatic microscopic hematuria (AMH) in adults: AUA guideline","volume":"188","author":"Davis","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2019.02.008_bib4","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/cncr.25048","article-title":"High risk patients with hematuria are not evaluated according to guideline recommendations","volume":"12","author":"Elias","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.pop.2019.02.008_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-5394.2002.106011.x","article-title":"Bladder cancer: epidemiology, diagnosis, and management","volume":"6","author":"Pashos","year":"2002","journal-title":"Cancer Pract"},{"key":"10.1016\/j.pop.2019.02.008_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/M15-1496","article-title":"Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American college of physicians","volume":"164","author":"Nielsen","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pop.2019.02.008_bib7","first-page":"748","article-title":"Assessment of asymptomatic microscopic hematuria in adults","volume":"11","author":"Sharp","year":"2013","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.pop.2019.02.008_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/clinchem\/38.3.426","article-title":"High incidence of significant urinary ascorbic acid concentrations in a west coast population\u2014implications for routine urinalysis","volume":"3","author":"Brigden","year":"1992","journal-title":"Clin Chem"},{"key":"10.1016\/j.pop.2019.02.008_bib9","first-page":"1594","article-title":"Anticoagulant associated hematuria: a prospective study","volume":"5","author":"Van Savage","year":"1995","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2019.02.008_bib10","series-title":"Expert panel on urologic imaging. ACR appropriateness criteria: hematuria","author":"Ramchandani","year":"2014"},{"issue":"6","key":"10.1016\/j.pop.2019.02.008_bib11","first-page":"2457","article-title":"Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria","volume":"168","author":"Gray Sears","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2019.02.008_bib12","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2214\/AJR.06.0676","article-title":"Comparison of effective radiation doses in patients undergoing unenhanced MDCT and excretory urography for acute flank pain","volume":"4","author":"Eikefjord","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.pop.2019.02.008_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2214\/AJR.07.2288","article-title":"Split-bolus MDCT urography with synchronous nephrographic and excretory phase enhancement","volume":"2","author":"Chow","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.pop.2019.02.008_bib14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2214\/AJR.07.2822","article-title":"Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue","volume":"4","author":"Wiginton","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.pop.2019.02.008_bib15","first-page":"1975","article-title":"Tumor markers in the diagnosis of primary bladder cancer. A systematic review","volume":"6","author":"Glas","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pop.2019.02.008_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.urology.2009.06.107","article-title":"Long-term outcome of patients with a negative work-up for asymptomatic microhematuria","volume":"1","author":"Madeb","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.pop.2019.02.008_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2010.09521.x","article-title":"Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up","volume":"2","author":"Edwards","year":"2011","journal-title":"BJU Int"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454319300119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454319300119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:43:35Z","timestamp":1758815015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454319300119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0095454319300119"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2019.02.008","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematuria","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}